Although there was a trend toward decreased risk of prostate cancer death with dose-escalated radiotherapy, it did not reach statistical significance, likely owing to a low event rate and lack of extended long-term follow-up.
← all excerpts
Conditional Risks of Biochemical Failure and Prostate Cancer-Specific Death in Patients Undergoing External Beam Radiotherapy: A Secondary Analysis of 2 Randomized Clinical Trials.
1
—
—